Optimization of regeneration and transformation parameters in tomato and improvement of its salinity and drought tolerance

As part of our efforts to improve tomato tolerance to abiotic stress, we have undertaken this study to introduce two candidate genes encoding: a sodium antiporter and a vacuolar pyrophosphatase, previously shown to enhance drought and salt tolerance in transgenic Arabidopsis plants. First, we evaluated the potential of primary leaves from three to four week-old in vitro-grown tomato seedlings as alternative explants to cotyledons for tomato transformation. Our results demonstrated that primaryleaves are three times more efficient then cotyledons in terms of regeneration percentage, productivity, and transformation frequencies independently of the medium and genetic construct used. Second,primary leaves were used to introduce the genes of interest using Agrobacterium-mediated transformation. Many transgenic tomato plants were easily recovered. The presence of the transgenes and their expression were confirmed by PCR and RT-PCR analysis. The transformation frequencies for primary leaf explants ranged from 4 to 10% depending on the genetic construct used. The time requiredfrom inoculation of primary leaves with Agrobacterium cells to transfer of transgenic tomato plants to soil was only 2 months compared to 3 to 4 months using standard tomato transformation protocols. The transgenic tomato plants obtained in the current study were more tolerant to salinity and drought stress than their wild-type counterparts

A serum substitute for fed-batch culturing of hybridoma cells

We developed a substitute for serum to produce fed-batch cultures of hybridoma cells in serum-free medium and confirmed that the cells could be successfully cultivated this way. Our substitute consisted of 12 components. The specific production rates of lactate and ammonia, which are harmful byproducts from the cells, were significantly reduced compared with a conventional serum-containing batch culture. This reduction led to a higher cell concentration and a longer production lifetime. As a result, the final concentration of monoclonal antibody was 400 mg/L, or five times greater than that in the conventional serum-containing batch culture. The developed substitute is expected to enable fed-batch cultivation in a serum-free condition